Electrical stimulation to reduce urinary incontinence in men after prostate cancer treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the effectiveness of the Elidah device, which uses electrical impulses to stimulate pelvic floor muscles, in reducing urinary incontinence in men who have undergone treatment for prostate cancer. Participants will use the device at home for 20 minutes a day, five days a week, over a period of six weeks. The study aims to assess the device's impact on urinary leakage, which is a common side effect of prostate cancer therapy. Participants will be monitored through daily logs and physical exams to track their progress.

Why it matters

Who can join: the full rules

* INCLUSION CRITERIA:
* Participants must be male.
* Participants must have a history of urinary incontinence for at least 6 months after local prostate cancer treatment.
* Participants must have at least one of the following types of urinary incontinence:

  * stress urinary incontinence, defined as involuntary loss of urine on effort or physical exertion (e.g., sporting activities) or on sneezing or coughing
  * urge urinary incontinence, defined as a compelling need to urinate, due to pain or an unpleasant sensation, that is difficult to defer.
* Participants must have moderate urinary incontinence defined as use of 1-4 pads per day by self-report at screening.
* Participants must be able to read and write in English.
* Age \>= 18 years.
* Eastern Cooperative Oncology Group (ECOG) performance status \<= 2.
* Ability to understand and the willingness to sign a written informed consent document.

EXCLUSION CRITERIA:

* Change of therapy for prostate cancer planned during the study intervention.
* History or symptoms of urinary retention (not an exclusion if this occurred before prostatectomy), extra-urethral incontinence, overflow incontinence.
* Active urinary tract infection (UTI) at screening or history of recurrent urinary tract infections (\>= 4 UTIs within the 12 months prior to the study treatment initiation).
* History of complete denervation of the pelvic floor.
* Severe obesity (body mass index \[BMI\] \>35).
* Pelvic pain/painful bladder syndrome.
* Metal implant in the abdominal or pelvic area.
* History of chronic cough with ongoing symptoms
* An implanted cardiac device, history of untreated cardiac arrhythmia, or history of other heart problems.
* History of epilepsy.
* History of underlying neurologic/neuromuscular disorder that could contribute to urinary incontinence.
* Change in medications prescribed for urinary incontinence within 2 weeks prior to the study treatment initiation.
* Uncontrolled intercurrent illness evaluated by medical history and physical examination or social situations that would limit compliance with study requirements.

Where it's running

• National Institutes of Health Clinical Center
  Bethesda, Maryland, United States Recruiting

Study contacts

• Principal investigator: Deborah E Citrin, M.D. — National Cancer Institute (NCI)
• Study coordinator: Debbie-Ann N Nathan, R.N.
• Email: dnathan@mail.nih.gov
• Phone: (240) 858-3103

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• See if increasing running cadence helps stress urinary incontinence in parous runners

  This study tests whether increasing running cadence by about 10% for eight weeks can reduce stress urinary incontinence symptoms in parous women who run regularly and own a Garmin watch.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07829692

• Prophylactic antibiotics to reduce post-procedure UTIs after urethral bulking

  We’re testing whether giving a preventive antibiotic at the time of urethral bulking can lower the chance of a urinary tract infection after the procedure for women with stress or mixed urinary incontinence.

  Recruiting at 2 sites Phase 4 University of Miami · Miami, Florida and 1 other locations · NCT07501065

• Neuspera SNM System follow-up: comparing patient experience with traditional SNM

  We’re testing whether patients who switch from a traditional sacral neuromodulation device to the Neuspera SNM System report similar or better experiences after about one month.

  Recruiting Neuspera Medical, Inc. · St Louis, Missouri · NCT07383688

• 30-minute Neuspera sacral neuromodulation for urinary urge incontinence

  This trial will try daily 30-minute sacral nerve stimulation with the Neuspera System to reduce urinary urge incontinence in adults who have not benefited from or cannot tolerate bladder medications.

  Recruiting Neuspera Medical, Inc. · West Columbia, South Carolina · NCT07247136

• Evaluating the impact of different mesh widths in surgery for urinary incontinence

  This study is testing whether using a wider surgical mesh during surgery for urinary incontinence in women can lead to better results and fewer problems.

  Recruiting Yuzuncu Yil University · Van · NCT06924450

• Evaluating postoperative activity restrictions after midurethral sling placement

  This study is testing whether patients who have had a midurethral sling procedure for stress urinary incontinence do better with strict activity limits or no limits after surgery.

  Recruiting University of Iowa · Iowa City, Iowa · NCT06840093

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.